We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Shire | SHP | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 4,690.00 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 4,690.00 | 4,690.00 |
| Top Posts |
|---|
Posted at 12/12/2018 16:22 by pete160 Thanks again redtom for all your updates.I sold the balance off my SHP this morning at 45.50. Not absolutely the top but, like you, a very good result.Now considering whether to reinvest ASAP or wait for the dust to settle.... |
Posted at 05/12/2018 18:25 by pete160 I'm minded to leave this a few days before selling the balance of my SHP and looking for a new home for the proceeds (after next weeks political shenanigans). I would be interested to hear what you might be currently looking at if you willing to share?My current watchlist comprises: Av, BP, Bats, Fres, HSBC, Lgen, Lloy, Saga, SLA, Standard Chartered. Unfortunately the rump of my SHP is not within an ISA or SIPP so a taxable income share is not a priority for this reinvestment. Currently leaning towards Fres which, to my thinking should rebound nicely when sentiment towards it changes or will be a good hedge against a further downturn if wider market sentiment doesn't. Similar thinking for Bats but they have heavy debt and I already have a large weighting in IMB in my sipp and isa. Others in mind, I moved the first half of my SHP into VOD so although sold half at £ 44 it did actually work out a good move. |
Posted at 05/12/2018 08:53 by pete160 Well done to redtom who has read this situation well all of the way through (and not been put off by moaning monty). A well deserved retirement for you perhaps?Also good to see that the Takeda shares lifted on the news which although perhaps a (partial) recovery of recent losses, is a move in the right direction nonetheless. Redtom - when you have a chance are you able to update the bid price, just interested how much head room we have left between now and planned completion in early Jan. Mind you, lots of potential opportunities to reinvest elsewhere in the next week or so, so I might well sell the remainder of my SHP and move on. |
Posted at 03/12/2018 09:55 by ali47fish when is the deadline if i want to sell my shares in shp please! |
Posted at 17/11/2018 10:03 by ali47fish i recieved my corporation letter -whilst shp has been rising takeda has been falling-should i still accept the offer or bank the profits |
Posted at 30/5/2018 09:03 by pete160 I also lightened up a few weeks ago, although still have 20% of pot in here, but I'm not sure I agree that the slide in the Takeda price is bad.The drop isn't really out of step with declines in the wider market and with the purchase partly funded with shares surely it provides Takeda holders some flexibility regardless of whether the share price halves or doubles? For SHP holders on the other hand, yes a reducing price is not necessarily good news - unless you are intending converting to Takeda to retain an exposure to SHP r&d going forward. But if the bid hadn't come along, what price do you think SHP would currently be trading at given that the market generally is down ? The self serving SHP directors hadn't exactly fallen over themselves to create value or comfort for their shareholders. If the bid hadn't come along I suspect SHP would currently be £ 26-28 / share, so even if the eventual Takeda bid is worth only say, £ 44, we are still much better off imo Finally, don't forget that between now and d'day sometime next Spring, presumably SHP is continuing to throw off bucket loads of cash. This was previously used to pay down debt rather than return to shareholders, but currently it is effectively reducing the risk to Takeda. |
Posted at 07/5/2018 09:52 by pete160 "if you were a Takeda shareholder, would you vote for it?"Yes, I would. As several people here have commented, they are likely getting SHP on the cheap (the Baxalta purchase is in for virtually nothing). In addition: The exchange rate is quite favourable for Takeda to make a foreign purchase The Japanese banks and government are willing their firms to expand and diversify The Japanese can borrow the money very cheaply, They are paying a large proportion in stock rather than cash We know that SHP creates a lot of cash They will already have a list of willing and cash rich buyers to buy the parts they don't want Takeda themselves need to get bigger or get swallowed themselves Takeda just need to accelerate plans to unlock SHP shareholder value, which the SHP bod have failed miserably to do, and the stock price will rebound very nicely. I wouldn't be at all surprised if, once the dust has settled and the surplus bits flogged at good prices, Takeda don't split up the larger entity along the lines that SHP should have done years ago. |
Posted at 05/5/2018 19:11 by pete160 Dealy, I agree.The market is already discounting that the deal will probably not proceed, otherwise SHP would be trading nearer to the bid value. If Takeda pull out (and I don't think they will) of course SHP will fall in the short term but I don't believe that it will fall to the multi-year lows seen prior to the bid speculation. By talking with Takeda, SHP has admitted that it is for sale. They have also admitted on the price they are willing to accept If however, a formal bid does not materialise and the SHP BOD do nothing to unlock shareholder value pdq they will either be on the receiving end of another bid or they will /should be on the receiving end of a P45. The exchange rate is more favourable to a bid for SHP than it has ever been, interest rates throughout the world are still at historically low levels for bidders to borrow and the silence of politicians over any loss of jobs, economic value, etc has been very telling. Anyone that believes that SHP is good value has a clear shot to buy it and the best shot that they will probably ever get. My guess for what it's worth, is that Takeda has the backing of shareholders in both companies and also the Japanese government and banks to pull off this deal. They will already have been approached by other parties to flip the parts of SHP that they don't want. |
Posted at 25/4/2018 07:04 by pete160 For those who are complaining, under the new offer (admittedly not yet paid) but we get £ 21.75 in cash. No so long ago SHP was trading at £ 29 (and still the bod did nothing for shareholder returns).With Takeda shares then, for not much risk I am therefore getting all of Shp's potential upside as well as Takeda's story as well and Takeda will be able to massively reduce the cost of the SHP borrowing either through lower japanese rates or from splitting or selling off the bits of SHP that SHP should have done. As for those who complain about US listed shares, the majority of significant holders, ie. not private investors, this really will not be an issue. How much of SHP is currently held be US investors anyway ? quite a bit. If people bemoan that Takeda have got a bargain at this price, it is the fault of the SHP bod, no-one else. rant over :-) |
Posted at 01/4/2018 12:21 by karateboy Let's summarise what we know and what happens if take over is successful:1. In 2014 a $54b takeover of SHP by Abbvie was called off due US tax rule. Is Abbvie still interested? 2. In 2016 SHP paid $32b for Baxalta..share price decline started then. However current share price does not give any value to this take over. 3. SHP and Tekeda combined will creat one of the biggest Pharma with revenue of $30b . I wonder if other big Pharma will let this to happen. So if Takeda makes the move, I believe other big Pharma may join the bid... 4. Takeda has no block buster drug in the pipeline, SHP has.so it may make sense for Takeda to take SHP over. 5. Takeda research centre is close by to SHP research centre in the USA...saving here... 6. Takeda CEO is ex big Pharma executive . He wants to run a big Pharma not just medium size Takeda. Interesting time ahead. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
